As of March 2024 Genocea Biosciences has a market cap of $0 Million. This makes Genocea Biosciences the world's 8393th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0 M | 0% |
2023 | $0 M | 0% |
2022 | $0 M | -99.99% |
2021 | $66.63 M | -46.67% |
2020 | $0.12 B | 119.89% |
2019 | $56.82 M | 128.35% |
2018 | $24.88 M | -25.26% |
2017 | $33.29 M | -71.53% |
2016 | $0.11 B | -21.18% |
2015 | $0.14 B | 18.72% |
2014 | $0.12 B |
On Mar 27th, 2024 the market cap of Genocea Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $158.46 B | 2,695,919,925.04% | ๐บ๐ธ USA |
Merck MRK | $333.77 B | 5,678,404,416.37% | ๐บ๐ธ USA |
Novavax NVAX | $0.66 B | 11,357,091.97% | ๐บ๐ธ USA |
Agenus
AGEN | $0.23 B | 4,048,699.73% | ๐บ๐ธ USA |
iBio IBIO | $15.57 M | 264,836.12% | ๐บ๐ธ USA |